Heart Outcomes Prevention Evaluation - HOPE-2

Description:

The goal of the trial was to evaluate the effect of treatment with homocysteine-lowering vitamins, folic acid, and vitamin B on cardiovascular outcomes among patients with pre-existing cardiovascular disease or diabetes.